Boston Scientific (MEX:BSX) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 05, 2026)


MEX:BSX Boston Scientific Corp MEX:BSX
85 GF Score
Price MXN784.12
GF Value MXN1,834.19
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Boston Scientific Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2026-07-05), Boston Scientific's Predictability Rank is 4-Stars. Boston Scientific's intrinsic value calculated from the Discounted Dividend model is MXN940.19 and current share price is MXN784.12. Consequently,

Boston Scientific's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is N/A.

MEX:BSX vs EW, GEHC, MDT: Margin of Safety % (DCF Dividends Based) Comparison

For the Medical Devices subindustry, Boston Scientific's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boston Scientific Margin of Safety % (DCF Dividends Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Margin of Safety % (DCF Dividends Based) falls into.


MEX:BSX
85GF Score
Boston Scientific Corp MEX:BSX
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boston Scientific Margin of Safety % (DCF Dividends Based) Calculation

Boston Scientific's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)=(Intrinsic Value: DCF (Dividends Based)-Current Price)/Intrinsic Value: DCF (Dividends Based)
=(0.00-784.12)/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

Is Boston Scientific (MEX:BSX) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of MXN784.12 is trading 57.2% below its estimated GF Value™ of MXN1,834.19. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for MEX:BSX:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: MXN1,834.19 vs. price of MXN784.12 (57.2% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
85GF Score

Get the complete analysis for MEX:BSX

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN784.12
Price
MXN1,834.19
GF Value